☰

Erika M. Wolff, Ph.D. - Publications

Affiliations: 
2009 Biochemistry and Molecular Biology University of Southern California, Los Angeles, CA, United States 
Area:
DNA methylation, cancer, epigenetics
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Gore J, Wolff E, Chisolm S, Lipman R, Smith A. Pd63-04 Engaging Stakeholders In Urologic Research: The Patient-Centered Design Of A Pragmatic Clinical Trial In Bladder Cancer The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557373.13509.A0  0.324
2016 Alsinnawi M, Cullen J, Wolff EM, Hurwitz LM, Levie K, Rosner IL, L’Esperance J, Brand TC, Sterbis JR, Slee A, Porter CR. Mp04-19 A Prospective Study Of Health Related Quality Of Life Outcomes For High Risk Prostate Cancer Patients Managed By Radical Prostatectomy Or Radiation Therapy With Androgen Deprivation Therapy The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1954  0.318
2016 Alsinnawi M, Slee AE, Banerji JS, Dahl KL, Akapame S, Massman JD, Wolff EM, Corman JM. Mp04-09 Does A Clear Understanding Of Life Expectancy Increase Decisional Conflict And Anxiety For Men With Newly Diagnosed Prostate Cancer? The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1944  0.321
2015 Banerji JS, Wolff EM, Massman JD, Odem-Davis K, Porter CR, Corman JM. Prostate Needle Biopsy Outcomes in the Era of the U.S. Preventive Services Task Force Recommendation Against Prostate Specific Antigen Based Screening. The Journal of Urology. PMID 26254722 DOI: 10.1016/J.Juro.2015.07.099  0.302
2015 Jeldres C, Cullen J, Hurwitz LM, Wolff EM, Levie KE, Odem-Davis K, Johnston RB, Pham KN, Rosner IL, Brand TC, L'Esperance JO, Sterbis JR, Etzioni R, Porter CR. Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy. Cancer. 121: 2465-73. PMID 25845467 DOI: 10.1002/Cncr.29370  0.341
2015 Banerji JS, Hurwitz LM, Cullen J, Odem-Davis K, Wolff EM, Levie K, Pham KN, Porter CR. Mp42-13 A Prospective Study Of Health-Related Quality Of Life Outcomes For Low-Risk Prostate Cancer Patients Managed By Active Surveillance Or Radiation Therapy The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1598  0.328
2014 Nichols CR, Jeldres C, Pham K, Daneshmand S, Kollmannsberger CK, Hayes-Lattin BM, Odem-Davis K, Wolff E, Porter CR. Influence of social demographics and African-American race on outcomes in testicular cancer: Analysis of 75,902 patients in the National Cancer database. Journal of Clinical Oncology. 32: 391-391. DOI: 10.1200/Jco.2014.32.4_Suppl.391  0.33
2014 Jeldres C, Nichols CR, Pham K, Daneshmand S, Kollmannsberger CK, Hayes-Lattin BM, Wolff E, Odem-Davis K, Porter CR. United States trends in patterns of care in clinical stage I testicular cancer: Results from the National Cancer Database (1998-2011). Journal of Clinical Oncology. 32: 369-369. DOI: 10.1200/Jco.2014.32.4_Suppl.369  0.373
2014 Pham K, Jeldres C, Johnston R, Cullen J, Odem-Davis K, Wolff E, Levie K, Hurwitz L, Porter C. Mp15-07 Health-Related Quality Of Life For Men With Low Risk Prostate Cancer Managed With Active Surveillance Compared To A Cancer-Screening Cohort Without Prostate Cancer The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.560  0.363
2014 Jeldres C, Nichols CR, Pham K, Daneshmand S, Kollmannsberger C, Hayes-Lattin B, Wolff E, Odem-Davis K, Porter CR. Mp10-05 Influence Of Race On Outcomes In Testicular Cancer: Analysis Of 75902 Patients In The National Cancer Data Base The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.461  0.374
2014 Pham K, Jeldres C, Corman J, Odem-Davis K, Wolff E, Porter C. Mp12-18 Focal Therapy For Prostate Cancer: The Utility Of A Confirmatory Transperineal Template Guided Prostate Biopsy To Identify Appropriate Candidates The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.453  0.305
2014 Jeldres C, Nichols CR, Pham K, Daneshmand S, Kollmannsberger C, Hayes-Lattin B, Wolff E, Odem-Davis K, Porter CR. Pd5-04 United States Trends In Patterns Of Care In Clinical Stage I Testicular Cancer: Results From The National Cancer Data Base (1998-2011) The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.407  0.329
2014 Jeldres C, Pham K, Johnston RB, Cullen J, Odem-Davis K, Wolff E, Levie K, Hurwitz L, Porter CR. Mp58-20 Health-Related Quality Of Life In Men Undergoing Active Surveillance Vs. Radical Prostatectomy For Low Risk Prostate Cancer: A Prospective Multi-Institutional Study The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1836  0.308
2012 Han H, Wolff EM, Liang G. Epigenetic alterations in bladder cancer and their potential clinical implications. Advances in Urology. 2012: 546917. PMID 22829811 DOI: 10.1155/2012/546917  0.546
2010 Wolff EM, Chihara Y, Pan F, Weisenberger DJ, Siegmund KD, Sugano K, Kawashima K, Laird PW, Jones PA, Liang G. Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue. Cancer Research. 70: 8169-78. PMID 20841482 DOI: 10.1158/0008-5472.Can-10-1335  0.57
2010 Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. Plos Genetics. 6: e1000917. PMID 20421991 DOI: 10.1371/Journal.Pgen.1000917  0.61
2010 Liang G, Wolff EM, Han HF, Byun H, Sharma S, Nichols P, Siegmund KD, Jones PA. Abstract 4801: Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer Cancer Research. 70: 4801-4801. DOI: 10.1158/1538-7445.Am10-4801  0.612
2010 Liang G, Wolff E, Chihara Y, Jones P. 1138 DNA METHYLATION PROFILING REVEALS DISTINCT PATTERNS BETWEEN INVASIVE AND NON-INVASIVE BLADDER TUMORS AND A FIELD DEFECT IN PREMALIGNANT TISSUES Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.637  0.384
2009 Choi SH, Worswick S, Byun HM, Shear T, Soussa JC, Wolff EM, Douer D, Garcia-Manero G, Liang G, Yang AS. Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer. International Journal of Cancer. Journal International Du Cancer. 125: 723-9. PMID 19437537 DOI: 10.1002/Ijc.24384  0.384
2009 Friedman JM, Liang G, Liu CC, Wolff EM, Tsai YC, Ye W, Zhou X, Jones PA. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Research. 69: 2623-9. PMID 19258506 DOI: 10.1158/0008-5472.CAN-08-3114  0.41
2008 Wolff EM, Liang G, Cortez CC, Tsai YC, Castelao JE, Cortessis VK, Tsao-Wei DD, Groshen S, Jones PA. RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. Cancer Research. 68: 6208-14. PMID 18676844 DOI: 10.1158/0008-5472.CAN-07-6616  0.613
2007 Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS. Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Research. 67: 10753-8. PMID 18006818 DOI: 10.1158/0008-5472.Can-07-0329  0.428
2005 Wolff EM, Liang G, Jones PA. Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer. Nature Clinical Practice. Urology. 2: 502-10. PMID 16474624 DOI: 10.1038/Ncpuro0318  0.52
Show low-probability matches.